References

  1. Grossniklaus HE, Green WR. Pathologic findings in pathologic myopia. Retina. 1992; 12(2):127-133. PubMed | Google Scholar

  2. Ohno-Matsui K, Yoshida T, Futagami S et al. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol. 2003; 87(5): 570-573. PubMed | Google Scholar

  3. Tufail A, Patel PJ, Sivaprasad S et al. Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study. Eye (Lond). 2013; 27(6):709-15. PubMed | Google Scholar

  4. Wolf S, Balciuniene VJ, Laganovska G et al. Radiance: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology. 2014; 12(3):682-92. PubMed | Google Scholar

  5. Yoon JU, Byun YJ, Koh HJ. Intravitreal antiVEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization. Retina. 2010; 30 (30):418-24. PubMed | Google Scholar

  6. De Bats F, Grange JD, Denis P, Kodjikian L. Néovaisseaux choroïdiens du myope fort naïfs traités par injections intravitréennes de bévacizumab: résultats à plus de 12 mois. J Fr Ophtalmol. 2013; 36(1):12-18. PubMed | Google Scholar

  7. Cornut PL, Poli M, Feldman A et al. Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month results. J Fr Ophtalmol. 2010; 33(5): 327-333. PubMed | Google Scholar

  8. Wakabayashi T, Ikuno Y, Gomi F. Different dosing of intravitreal bevacizumab for choroidal neovascularization because of pathologic myopia. Retina. 2011; 31(5): 880-886. PubMed | Google Scholar

  9. Wong TY, Ohno-Matsui K, Leveziel N et al. Myopic choroidal neovascularisation: current concepts and update on clinical management. Br J Ophthalmol. 2014; 0:1-8. PubMed | Google Scholar

  10. Leveziel N, Quaranta-El Maftouhi M, Lalloum F et al. Traitement de la néovascularisation choroïdienne secondaire à la myopie forte : recommandations de la Fédération France Macula. J Fr Ophtalmol. 2014; 37(4):320-328. PubMed | Google Scholar